Drug deal

Ex-PM Ehud Barak to chair medical cannabis firm InterCure

Company to employ former Israeli leader to lead its global growth strategy for a 40-hour-per-month job that will pay $10,000

Former Israeli prime minister Ehud Barak attends a conference marking the 50th anniversary of the Six-Day War, at the Ben Zvi Institute in Jerusalem on June 5, 2017. (Yonatan Sindel/Flash90)
Former Israeli prime minister Ehud Barak attends a conference marking the 50th anniversary of the Six-Day War, at the Ben Zvi Institute in Jerusalem on June 5, 2017. (Yonatan Sindel/Flash90)

Former prime minister Ehud Barak will become chairman of one of Israel’s biggest medical cannabis firms and will lead its global growth strategy, the company and Barak announced on Tuesday.

InterCure, which is publicly traded in Israel and weighing whether to launch its stock on the Nasdaq market as well, is currently in the process of purchasing medical cannabis company Canndock and will eventually change its name to Canndock Pharma.

Canndock has for the last decade been a pioneer in researching, growing and marketing medical cannabis, according to a statement carried by Hebrew-language media.

Barak, who was Israel’s leader between 1999 and 2001, will work 40 hours a month for InterCure and earn $10,000 (NIS 35,800), the statement said.

Cannabis plant (Kobi Gideon/Flash90)

He will also receive stock options worth 5 percent of the company, it added.

“I am happy to join the senior management of the company,” said Barak, who has also served as defense minister. “Medical cannabis has proven potential to help and improve the lives of many patients around the world, and central Western countries have adopted and are adopting it as recognized medical treatment.”

“I intend to lead Canndock Pharma to be a world leader in its field,” he added.

Most Popular
read more:
If you’d like to comment, join
The Times of Israel Community.
Join The Times of Israel Community
Commenting is available for paying members of The Times of Israel Community only. Please join our Community to comment and enjoy other Community benefits.
Please use the following structure: example@domain.com
Confirm Mail
Thank you! Now check your email
You are now a member of The Times of Israel Community! We sent you an email with a login link to . Once you're set up, you can start enjoying Community benefits and commenting.